Cargando…
Clinical features and the efficacy of adjuvant chemotherapy in resectable small bowel adenocarcinoma: a single-center, long-term analysis
BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare gastrointestinal malignancy. There is no standard regimen for adjuvant chemotherapy for treating SBA. This study aimed to assess the efficacy of adjuvant chemotherapy in patients with resectable SBA. METHODS: This retrospective study collected d...
Autores principales: | Li, Ning, Shen, Wei, Deng, Wenying, Yang, Han, Ma, Yijie, Bie, Liangyu, Wei, Chen, Luo, Suxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475383/ https://www.ncbi.nlm.nih.gov/pubmed/32953749 http://dx.doi.org/10.21037/atm-20-1503 |
Ejemplares similares
-
Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study
por: Ma, Yijie, et al.
Publicado: (2022) -
Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
por: Nishioka, Yuri, et al.
Publicado: (2023) -
Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors
por: Wei, Chen, et al.
Publicado: (2022) -
Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
por: Li, Ning, et al.
Publicado: (2021) -
Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma
por: Ye, Xiaojian, et al.
Publicado: (2018)